Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SR 202, Tocris Bioscience™

Catalog No. 202250
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Selective PPARγ antagonist; antidiabetic and antiobesity agent

Selective PPARγ antagonist; antidiabetic and antiobesity agent. Attenuates troglitazone-induced PPARγ transcriptional activity (IC50 = 140 μM) without affecting ligand-stimulated PPARα, PPARβ or FXR transcriptional activity. Inhibits PPARγ-dependent adipocyte differentiation and growth in vitro and in vivo. Improves insulin sensitivity in diabetic ob/ob mice and increases HDL levels in rats in vivo.

Chemical Identifiers

CAS 76541-72-5
Molecular Formula C11H17ClO7P2
Molecular Weight (g/mol) 358.648
InChI Key VQHUQHAPWMNBLP-UHFFFAOYSA-N
Synonym mifobate, clenicor, mifobatum latin, mifobato spanish, mifobate usan:inn, 4-chlorophenyl dimethoxyphosphinyl methyl phosphoric acid dimethyl ester, dimethyl alpha-dimethoxyphosphinyl-p-chlorobenzyl phosphate, dimethyl p-chloro-alpha-hydroxybenzyl phosphonate, dimethyl phosphate, phosphoric acid, 4-chlorophenyl dimethoxyphosphinyl methyl dimethyl ester, dsstox_cid_25741
PubChem CID 60910
IUPAC Name [(4-chlorophenyl)-dimethoxyphosphorylmethyl] dimethyl phosphate
SMILES COP(=O)(C(C1=CC=C(C=C1)Cl)OP(=O)(OC)OC)OC

Specifications

Quantity 50 mg
Formula Weight 358.65
Percent Purity >99%
Chemical Name or Material SR 202
Recommended Storage Desiccate at Room Temperature
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.